SyntekaBio, Inc. (KOSDAQ:226330)

South Korea · Delayed Price · Currency is KRW

1,528.00

+96.00 (6.70%)

At close: Aug 3, 2026

SyntekaBio Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,983	3,429	120.89	123.41	243.99	316.66
Revenue Growth	203.28%	2736.72%	-2.04%	-49.42%	-22.95%	-48.06%
Gross Profit	2,979	3,425	116.97	120.92	233.04	301.42
Operating Income	-11,313	-10,765	-14,270	-12,276	-11,792	-8,891
Net Income	-13,577	-17,378	-7,213	-11,398	-4,506	-14,803
Earnings Per Share	-761.51	-1115.48	-473.00	-796.14	-333.47	-1099.43
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	13,397	16,346	12,066	19,668	35,342	52,709
Total Debt	7,797	7,126	7,314	2,094	11,121	8,836
Net Cash (Debt)	5,601	9,219	4,752	17,574	24,222	43,873
Net Cash Growth	-	94.01%	-72.96%	-27.45%	-44.79%	9.50%
Net Cash Per Share	314.12	591.78	311.60	1227.54	1792.34	3258.50

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-10,366	-10,650	-10,509	-8,078	-8,511	-6,040
Capital Expenditures	-176.08	-11.01	-5,707	-9,364	-8,389	-7,479
Free Cash Flow	-10,542	-10,661	-16,216	-17,442	-16,899	-13,520
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	99.88%	99.87%	96.76%	97.99%	95.51%	95.19%
Operating Margin	-379.27%	-313.91%	-11804.01%	-9947.91%	-4832.99%	-2807.83%
Pretax Margin	-455.20%	-506.76%	-5966.88%	-9235.91%	-1846.96%	-4674.69%
Profit Margin	-455.20%	-506.76%	-5966.88%	-9235.91%	-1846.96%	-4674.69%
FCF Margin	-353.44%	-310.88%	-13413.89%	-14133.89%	-6926.24%	-4269.46%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	12.43	17.33	662.66	1757.47	475.35	763.13